Biomerica Inc. (NASDAQ:BMRA) price on Thursday, March 28, fall -6.52% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.83.
A look at the stock’s price movement, the close in the last trading session was $0.89. The beta value (5-Year monthly) was -1.01. Turning to its 52-week performance, $2.13 and $0.70 were the 52-week high and 52-week low respectively. Overall, BMRA moved -32.36% over the past month.
Biomerica Inc.’s market cap currently stands at around $13.99 million, with investors looking forward to this quarter’s earnings report slated for Apr 12, 2024 – Apr 16, 2024.
Wall Street analysts have also projected the company’s year-on-year revenue for 2024 to grow to $26.59 million, representing a 398.00% jump on that reported in the last financial year.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that BMRA is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
BMRA’s current price about -21.63% and -18.13% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 31.30, while 7-day volatility ratio is 13.21% and 8.34% in the 30-day chart. Further, Biomerica Inc. (BMRA) has a beta value of -1.04, and an average true range (ATR) of 0.09.
If we refocus on Biomerica Inc. (NASDAQ:BMRA), historical trading data shows that trading volumes averaged 59780.0 over the past 10 days and 89.57K over the past 3 months. The company’s latest data on shares outstanding shows there are 16.82 million shares.
The 7.30% of Biomerica Inc.’s shares are in the hands of company insiders while institutional holders own 22.67% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 76730.0 on Mar 15, 2024, giving us a short ratio of 1.48. The data shows that as of Mar 15, 2024 short interest in Biomerica Inc. (BMRA) stood at 0.46% of shares outstanding, with shares short falling to 0.14 million registered in Feb 15, 2024. Current price change has pushed the stock -33.44% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BMRA stock continues to rise going into the next quarter.
